Stockreport

How The DarioHealth (DRIO) Story Is Shifting With A Higher Target And Ongoing Risks [Yahoo! Finance]

DarioHealth Corp.  (DRIO) 
NASDAQ:AMEX Investor Relations: dariohealth.com/our-story
PDF holding long term revenue growth assumptions at roughly 11.40%. These small shifts reflect analysts trying to balance a higher stated price target of US$11 with a cautio [Read more]